Tvaster Genkalp Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.26M
- Investors
-
3
Tvaster Genkalp General Information
Description
Developer of tumorigenesis blood-based epigenetic markers designed for cancer diagnostics. The company's markers use multiple advanced liquid biopsy methodologies to offer a screening test for hepatocellular carcinoma, enabling healthcare professionals to enhance early cancer detection and improve patient outcomes.
Contact Information
Website
www.tvastergen.comCorporate Office
- C604-605, 6th Floor, C-Block, IIT Madras Research Park
- Kanagam Road, Tharamani
- Chennai, Tamilnadu 600113
- India
Corporate Office
- C604-605, 6th Floor, C-Block, IIT Madras Research Park
- Kanagam Road, Tharamani
- Chennai, Tamilnadu 600113
- India
Tvaster Genkalp Timeline
Tvaster Genkalp Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Apr-2025 | $1.26M | Completed | Clinical Trials - General | ||
| 1. Seed Round | 19-Sep-2023 | Completed | Startup |
Tvaster Genkalp Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| CCPS | ||||||||
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Tvaster Genkalp Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tvaster Genkalp Patents
Tvaster Genkalp Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4705519-A1 | Sequencing independent compositions for detecting carcinomas using methylation markers | Pending | 29-Apr-2023 | ||
| WO-2024228094-A4 | Sequencing independent compositions for detecting carcinomas using methylation markers | Inactive | 29-Apr-2023 |
Tvaster Genkalp Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tvaster Genkalp Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ideaspring Capital | Venture Capital | Minority | ||
| Invigo Softwares | Corporation | Minority | ||
| Angel (individual) | Minority |
Tvaster Genkalp FAQs
-
When was Tvaster Genkalp founded?
Tvaster Genkalp was founded in 2021.
-
Where is Tvaster Genkalp headquartered?
Tvaster Genkalp is headquartered in Chennai, India.
-
What is the size of Tvaster Genkalp?
Tvaster Genkalp has 8 total employees.
-
What industry is Tvaster Genkalp in?
Tvaster Genkalp’s primary industry is Diagnostic Equipment.
-
Is Tvaster Genkalp a private or public company?
Tvaster Genkalp is a Private company.
-
What is the current valuation of Tvaster Genkalp?
The current valuation of Tvaster Genkalp is .
-
What is Tvaster Genkalp’s current revenue?
The current revenue for Tvaster Genkalp is .
-
How much funding has Tvaster Genkalp raised over time?
Tvaster Genkalp has raised $1.39M.
-
Who are Tvaster Genkalp’s investors?
Ideaspring Capital, Invigo Softwares, and have invested in Tvaster Genkalp.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
